MORPHINE-3,6-DIGLUCURONIDE TETRAHYDRATE, DEA SCHEDULE II
Morphine-3,6-diglucuronide tetrahydrate, To be determined
4'-HYDROXYWARFARIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
TOLMETIN SODIUM DIHYDRATE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS
MEVINOLIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
INDOMETHACIN CRYSTALLINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS
CYTOCHROME P450 CYP2C9 ISOZYME
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, OXIDATIVE PATHWAY
OXIDIZED NIFEDIPINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
MIDAZOLAM-(METHYL,1,3A,4-13C4-5-15N) MALEATE SALT, DEA SCHEDULE III
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
MXR-MEMBRANE PREPARATION, HUMAN
MXR human, membrane preparation, wild type variant, for Vesicular Transport
UDP-GLUCURONOSYLTRANSFERASE SF9WT
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, CONJUGATE PATHWAY